Rhythm Pharmaceuticals Inc
(NAS:RYTM)
$
55.59
-0.95 (-1.68%)
Market Cap: 3.47 Bil
Enterprise Value: 3.14 Bil
PE Ratio: 0
PB Ratio: 308.96
GF Score: 58/100 Rhythm Pharmaceuticals Inc at Bank of America Biotech SMID Cap Conference Transcript
Dec 08, 2022 / 02:40PM GMT
Release Date Price:
$26.38
(-3.76%)
Operator
Ladies and gentlemen, the program is about to begin. Reminder that you can submit questions at any time via the Ask Questions tab on the webcast page. At this times, it's my pleasure to turn the program over to your hist, Tazeen Ahmad.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Okay. Great. Thank you, and good morning, everybody. Thanks for continuing to participate with us at our Virtual SMID Biotech Conference. It's my pleasure to have my next presenting company with me, Rhythm Pharmaceuticals. And with me for the next 30 minutes or so is CEO, David Meeker. Good morning, David. Thanks for joining us.
David P. Meeker
Rhythm Pharmaceuticals, Inc. - Chairman, President & CEO
Good morning, Tazeen. Thank you.
Tazeen Ahmad
BofA Securities, Research Division - MD in Equity Research & Research Analyst
Well, for those who may not be as familiar with Rhythm, I thought maybe we should do a quick intro of the company.
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot